Chime Financial, Inc. Class A Common Stock
NASDAQ:CHYMBanks - Regional
+$0.15 today
- Market cap
- $12.16B
- Beta
- 0.76
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$2.54
Volume 5.80M
Average 4.76M
CHYM EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Chime Financial, Inc. Class A Common StockNASDAQ: CHYM
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA turns positive
Q2 FY2026 EBITDA was $35.62M, compared with -$923.23M a year earlier. Trailing-twelve-month EBITDA was -$5.95M.
Context
- EBITDA amounted to 44.8% of revenue in FY2025, up 42.6 pp from a year earlier.
- EBITDA grew in size in 1 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 16 analysts of $270.4M (+127.6%) for the fiscal year ending Dec 2026, a step up from the -2558.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $35.62M-42.2% QoQ
- Last fiscal yearDec 2025
- -$979.11M-2558.5% YoY
- LTMJun 2026
- -$5.95M+99.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +103.9% | +194.0% | +90.1 pp |
| 1 year | -2558.5% | +127.6% | +2686.1 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (979.11M) USD
- Year-over-year change
- -2558.5%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (979.11M) | -2558.5% |
| FY2024 | 2024-12-31 | (36.83M) | +83.5% |
| FY2023 | 2023-12-31 | (222.85M) | +52.7% |
| FY2022 | 2022-12-31 | (471.4M) | — |
EBITDA vs competitors
How CHYM compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +99.4% is the 2nd highest of 7, against a peer median of +26.4%.
- EBITDA amounts to 0.3% of revenue for CHYM, versus a peer median of 35.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | ¥128.96B JPY | +79.4% | — | 32.6% | |
| LTM Jun 2026 | $22.17B USD | +21.8% | +16.6% | 63.2% | |
| LTM Jun 2026 | $7.74B USD | +6.6% | +15.6% | 22.7% | |
| LTM Sep 2026 | $4.78B USD | +30.9% | — | 23.0% | |
| LTM Jun 2026 | $3.91B USD | -1.2% | +14.2% | 38.3% | |
| LTM Jun 2026 | $294.82M USD | +276.1% | — | 45.8% | |
| LTM Jun 2026 | -$5.95M USD | +99.4% | — | 0.3% | |
| Peer median (excluding CHYM) | — | +26.4% | +15.6% | 35.5% | |
Competitors are the stored peer set for CHYM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 1.01B | 1.28B | 1.67B | 2.19B |
| Cost of Revenue | 214.69M | 219.74M | 207.51M | 309.03M |
| Gross Profit | 794.15M | 1.06B | 1.47B | 1.88B |
| Gross Margin | 78.7% | 82.8% | 87.6% | 85.9% |
| Research & Development | 242.43M | 259M | 309.58M | 934.93M |
| Selling, General & Admin | 603.94M | 598.75M | 696.99M | 1.15B |
| Operating Expenses | 1.27B | 1.29B | 1.53B | 2.92B |
| Depreciation & Amortization | 7.3M | 12.94M | 25.37M | 30M |
| EBITDA | (471.4M) | (222.85M) | (36.83M) | (979.11M) |
| EBITDA Margin | -46.7% | -17.4% | -2.2% | -44.8% |
| Operating Income | (478.7M) | (235.79M) | (62.2M) | (1.04B) |
| Operating Margin | -47.5% | -18.4% | -3.7% | -47.6% |
| Interest Income | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 8.11M | 32.82M | 39.47M | 30.87M |
| Income Before Tax | (470.59M) | (202.97M) | (22.73M) | (1.01B) |
| Pre-Tax Margin | -46.6% | -15.9% | -1.4% | -46.1% |
| Income Tax Expense | (337K) | 234K | 2.61M | 831K |
| Net Income | (470.25M) | (203.2M) | (25.34M) | (1.01B) |
| Net Margin | -46.6% | -15.9% | -1.5% | -46.2% |
| EPS (Basic) | (1.29) | (0.56) | (0.07) | (2.67) |
| EPS (Diluted) | (1.29) | (0.56) | (0.07) | (2.60) |
| Weighted Avg Shares | 364.42M | 364.42M | 364.42M | 378.75M |
| Weighted Avg Shares (Diluted) | 364.42M | 364.42M | 364.42M | 388.17M |
Chime Financial, Inc. Class A Common Stock
NASDAQ:CHYM
Intrinsic Alpha fair value
Locked
Current Price
$32.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.